Pfizer (PFE) Stock
NASDAQ · PFE
27.66
Fundamentals
Market cap
$157.65B
Price / Earnings ratio
36.4x
Price / Sales ratio
2.5x
Price / Book ratio
1.9x
Return on assets
0.0%
Ex-Dividend date
24 Jul 2026
Last payment date
N/A
Dividend amount
$0.43
Dividend yield
6.2%
Debt / Equity ratio
N/A
Latest news
About Pfizer
At Pfizer, we apply science and our global resources to bring therapies and healthcare products to people that extend and significantly improve their lives. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees75,000
CEODr. Albert Bourla D.V.M., Ph.D.
IPO DateJun 22, 1942
HeadquartersNew York, NY
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Albert Bourla D.V.M., Ph.D. | Chairman of the Board & CEO | 1962 |
| Dr. Chris Boshoff FMedSci, M.D., Ph.D. | Chief Scientific Officer and President of Research & Development | 1964 |
| Mr. Douglas M. Lankler | Executive VP & Chief Legal Officer | 1966 |
| Mr. Aamir Malik | Executive VP & Chief U.S. Commercial Officer | 1976 |
| Ms. Cecile Guegan | Interim CFO & Executive VP | 1971 |
| Ms. Jennifer B. Damico | Senior VP, Controller & Principal Accounting Officer | 1969 |
| Mr. Dennis P. Hancock | Executive VP & Chief Information Officer | — |
| Ms. Francesca M. DeMartino | Chief Investor Relations Officer | — |
| Ms. Payal Sahni Becher | Chief People Experience Officer & Executive VP | 1975 |
| Dr. Michael S. Vincent M.D., Ph.D. | Senior VP and Chief Scientific Officer of Inflammation & Immunology | — |
Fundamentals
Valuation
Market cap$157.65B
Price-to-sales ratio2.47
Price-to-book value1.85
Price-earnings ratio36.40
Return on Equity8.00%
Return on Sales0.12%
Return on Assets0.04%
PEG ratio12.56
Earnings Per Share
Earnings Per Share$0.76
Income Statement
Average volume33,073,852
EBITDA$14.46B
1 year high (52w)$29.21
1 year low (52w)$23.58
Dividend
Ex dividend date24 Jul 2026
Dividend amount$0.43
Dividend yield6.22%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



